Stephen L Moff, MD
Gastroenterology · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Moff’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A78482 · Current
Licensed to practise in California · since 2002 · expires 2027-11-30 · Duke University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Drugs they prescribed that Part D paid
$243,035
Pharmacies billed $243,035 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 523) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
446 generic and 77 brand-name prescriptions · $243,035 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mesalamine | 50 | $16,989 | $340 |
| Alosetron | 11 | $5,593 | $508 |
| Gavilyte-C | 238 | $5,356 | $23 |
| Budesonide Dr | 32 | $2,513 | $79 |
| Sulfasalazine | 11 | $625 | $57 |
See all 8 drugs
| Mesalamine | 50 | $16,989 | $340 |
| Alosetron | 11 | $5,593 | $508 |
| Gavilyte-C | 238 | $5,356 | $23 |
| Budesonide Dr | 32 | $2,513 | $79 |
| Sulfasalazine | 11 | $625 | $57 |
| Lactulose | 11 | $587 | $53 |
| Metoclopramide | 19 | $308 | $16 |
| Ondansetron | 13 | $74 | $6 |
Year by year
| 2024 | 523 | 321 | 0% (0) | 15% | $243,035 |
| 2023 | 499 | 266 | None | 20% | $222,873 |
| 2022 | 498 | 285 | 2% (11) | 30% | $210,580 |
| 2021 | 424 | 249 | 0% (0) | None | $154,795 |
| 2020 | 411 | 237 | 0% (0) | None | $107,130 |
| 2019 | 413 | 283 | 0% (0) | None | $143,309 |
| 2018 | 416 | 283 | None | 47% | $167,303 |
| 2017 | 418 | 266 | 0% (0) | 31% | $239,480 |
| 2016 | 453 | 271 | 0% (0) | 34% | $324,904 |
| 2015 | 383 | 199 | 0% (0) | 42% | $285,280 |
| 2014 | 278 | 114 | 0% (0) | 49% | $207,141 |
| 2013 | 245 | 114 | None | None | $137,672 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Xifaxan | 12 | $44,454 | $3,704 |
| Mesalamine | 38 | $15,352 | $404 |
| Lialda | 19 | $12,052 | $634 |
| Linzess | 11 | $11,979 | $1,089 |
| Alosetron | 12 | $6,102 | $508 |
| Gavilyte-C | 193 | $3,989 | $21 |
| Lactulose | 20 | $2,393 | $120 |
| Budesonide Dr | 23 | $1,724 | $75 |
| Mercaptopurine | 12 | $796 | $66 |
| Cholestyramine | 14 | $536 | $38 |
| Diphenoxylate-Atropine | 11 | $214 | $19 |
| Omeprazole | 12 | $127 | $11 |
2022: 12 drugs
| Zenpep | 12 | $57,126 | $4,761 |
| Linzess | 22 | $20,280 | $922 |
| Lialda | 26 | $15,661 | $602 |
| Mesalamine | 21 | $6,700 | $319 |
| Gavilyte-C | 175 | $3,060 | $17 |
| Lactulose | 20 | $2,484 | $124 |
| Mercaptopurine | 16 | $2,028 | $127 |
| Budesonide Dr | 11 | $769 | $70 |
| Peg-3350 and Electrolytes | 38 | $766 | $20 |
| Cholestyramine | 15 | $615 | $41 |
| Omeprazole | 25 | $300 | $12 |
| Tramadol | 11 | $97 | $9 |
2021: 9 drugs
| Xifaxan | 11 | $41,814 | $3,801 |
| Lialda | 43 | $23,007 | $535 |
| Mesalamine | 38 | $17,707 | $466 |
| Budesonide Ec | 16 | $2,120 | $132 |
| Mercaptopurine | 11 | $2,048 | $186 |
| Lactulose | 17 | $2,033 | $120 |
| Peg-3350 and Electrolytes | 79 | $1,592 | $20 |
| Gavilyte-C | 92 | $1,440 | $16 |
| Peg 3350-Electrolyte | 16 | $432 | $27 |
2020: 7 drugs
| Mesalamine | 37 | $14,272 | $386 |
| Lialda | 19 | $12,379 | $652 |
| Budesonide Ec | 27 | $3,683 | $136 |
| Gavilyte-C | 123 | $2,342 | $19 |
| Omeprazole | 26 | $493 | $19 |
| Peg-3350 and Electrolytes | 22 | $471 | $21 |
| Gavilyte-G | 11 | $249 | $23 |
2019: 7 drugs
| Lialda | 12 | $17,106 | $1,426 |
| Mesalamine | 15 | $7,706 | $514 |
| Gavilyte-C | 201 | $7,267 | $36 |
| Budesonide Ec | 36 | $4,025 | $112 |
| Sulfasalazine | 11 | $1,056 | $96 |
| Omeprazole | 30 | $438 | $15 |
| Gavilyte-G | 11 | $266 | $24 |
2018: 6 drugs
| Lialda | 21 | $38,072 | $1,813 |
| Budesonide Ec | 27 | $5,801 | $215 |
| Gavilyte-C | 127 | $4,542 | $36 |
| Mercaptopurine | 11 | $4,193 | $381 |
| Peg 3350-Electrolyte | 88 | $3,186 | $36 |
| Omeprazole | 15 | $272 | $18 |
2017: 9 drugs
| Humira | 11 | $66,256 | $6,023 |
| Lialda | 23 | $40,856 | $1,776 |
| Canasa | 12 | $30,153 | $2,513 |
| Budesonide Ec | 32 | $24,605 | $769 |
| Xifaxan | 11 | $21,518 | $1,956 |
| Truvada | 11 | $17,077 | $1,552 |
| Gavilyte-C | 208 | $3,548 | $17 |
| Sulfasalazine | 13 | $2,426 | $187 |
| Omeprazole | 26 | $831 | $32 |
2016: 8 drugs
| Humira | 24 | $149,087 | $6,212 |
| Canasa | 17 | $34,410 | $2,024 |
| Lialda | 18 | $32,013 | $1,778 |
| Budesonide Ec | 32 | $30,472 | $952 |
| Mercaptopurine | 16 | $4,287 | $268 |
| Gavilyte-C | 201 | $3,417 | $17 |
| Ursodiol | 11 | $2,249 | $204 |
| Omeprazole | 13 | $621 | $48 |
2015: 12 drugs
| Humira | 17 | $93,125 | $5,478 |
| Budesonide Ec | 39 | $44,484 | $1,141 |
| Pentasa | 21 | $42,564 | $2,027 |
| Lialda | 22 | $37,030 | $1,683 |
| Canasa | 13 | $27,522 | $2,117 |
| Zenpep | 15 | $11,000 | $733 |
| Balsalazide Disodium | 15 | $7,324 | $488 |
| Mercaptopurine | 12 | $3,678 | $307 |
| Hydrocortisone | 18 | $3,534 | $196 |
| Ursodiol | 15 | $3,210 | $214 |
| Gavilyte-C | 124 | $2,120 | $17 |
| Omeprazole | 11 | $911 | $83 |
2014: 9 drugs
| Humira | 12 | $50,395 | $4,200 |
| Budesonide Ec | 38 | $49,902 | $1,313 |
| Lialda | 19 | $27,225 | $1,433 |
| Canasa | 12 | $21,573 | $1,798 |
| Pentasa | 12 | $19,361 | $1,613 |
| Balsalazide Disodium | 12 | $5,035 | $420 |
| Carafate | 11 | $3,448 | $313 |
| Omeprazole | 14 | $793 | $57 |
| Gavilyte-C | 27 | $459 | $17 |
2013: 5 drugs
| Budesonide Ec | 20 | $42,550 | $2,128 |
| Lialda | 19 | $20,817 | $1,096 |
| Colocort | 13 | $3,685 | $283 |
| Omeprazole | 14 | $872 | $62 |
| Gavilyte-C | 38 | $646 | $17 |
Money from drug and device companies
$43 in 2024
A payment is not proof that care is biased.
| Boston Scientific | Exalt Model D | $43 | 1 payment
|
See the published payment
| Boston Scientific | Meals · 2024-02-23 | Exalt Model D | $43 |
Professional record
- NPI
- 1093892945
- Licence
- CA A78482California A78482: Current · expires 2027-11-30
- Trained
- Duke University School of Medicine, 1999
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A784820
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 1800 Harrison St Fl 7, Oakland, CA, 94612
- NPI first listed
- 2006-10-31
- NPI last updated
- 2021-12-20
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.